Altimmune Inc (ALT) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
420.00%
0.026
|
0.005 | 0.005 | 0.005 | 0.005 |
|
|
38.61%
28.92
|
20.86 | 22.93 | 21.82 | 24.77 |
| Benefits Costs and Expenses |
43.98%
27.38
|
19.02 | 22.15 | 20.26 | - |
| Costs And Expenses |
43.98%
27.38
|
19.02 | 22.15 | 20.26 | 24.77 |
| Operating Income/Loss |
38.52%
-28.89
|
-20.86 | -22.92 | -21.82 | -24.77 |
| Nonoperating Income/Loss |
16.80%
1.535
|
1.845 | 0.776 | 1.559 | 1.922 |
| Income/Loss From Continuing Operations Before Tax |
43.88%
-27.36
|
-19.01 | -22.15 | -20.26 | 0.005 |
| Income Tax Expense/Benefit, Deferred |
-
|
- | - | -0.681 | - |
| Income Tax Expense/Benefit |
-
|
- | - | -0.681 | - |
| Income/Loss From Continuing Operations After Tax |
43.88%
-27.36
|
-19.01 | -22.15 | -19.57 | -22.84 |
|
|
43.88%
-27.36
|
-19.01 | -22.15 | -19.57 | -22.84 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
93.40%
5.9056
|
89.42 | 81.48 | 75.55 | 71.08 |
| Diluted Average Shares |
93.40%
5.9056
|
89.42 | 81.48 | 75.55 | 71.08 |
| Basic Earnings Per Share |
23.81%
-0.26
|
-0.21 | -0.27 | -0.26 | -0.32 |
| Diluted Earnings Per Share |
23.81%
-0.26
|
-0.21 | -0.27 | -0.26 | -0.32 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):